Podcasts about reanima project

Ira Pastor - Chief Executive Officer – Bioquark Inc. (www.bioquark.com) - Over 30 years of experience across multiple sectors of the pharmaceutical industry including pharmaceutical commercialization, biotech drug development, managed care, distribution, OTC, and retail; Served as VP, Business Development for drug development company Phytomedics Inc., raising $40 million of private equity, consummating over $50 million of licensing deals, and bringing lead drug candidate from discovery stage to Phase III development; Prior to that, employed by SmithKline Beecham Pharmaceuticals working in sales, marketing, and business strategy positions. Mr. Pastor has also served as Vice President of Corporate Development for the pharmacy benefit management company Prescription Delivery Systems (acquired by Cigna Health Insurance); MBA, Temple University; BS, Pharmacy, Rutgers University; He is also a Board Member of RegenerAge SAPI de CV, (www.regenerage.clinic/en/) a clinical company focused on expedited translational therapeutic applications of regenerative and rejuvenative healthcare interventions, the Reanima Project (http://www.reanima.tech), member of the Executive Council of the World Academy of Medical Science – WAMS (https://wams.online/our_team/ira-s-pastor/), and member of the World Economic Forum's Human Enhancement council (https://www.weforum.org/people/ira-pastor).

Ira Pastor - Chief Executive Officer – Bioquark Inc. (www.bioquark.com) - Over 30 years of experience across multiple sectors of the pharmaceutical industry including pharmaceutical commercialization, biotech drug development, managed care, distribution, OTC, and retail; Served as VP, Business Development for drug development company Phytomedics Inc., raising $40 million of private equity, consummating over $50 million of licensing deals, and bringing lead drug candidate from discovery stage to Phase III development; Prior to that, employed by SmithKline Beecham Pharmaceuticals working in sales, marketing, and business strategy positions. Mr. Pastor has also served as Vice President of Corporate Development for the pharmacy benefit management company Prescription Delivery Systems (acquired by Cigna Health Insurance); MBA, Temple University; BS, Pharmacy, Rutgers University; He is also a Board Member of RegenerAge SAPI de CV, (www.regenerage.clinic/en/) a clinical company focused on expedited translational therapeutic applications of regenerative and rejuvenative healthcare interventions, the Reanima Project (http://www.reanima.tech), member of the Executive Council of the World Academy of Medical Science – WAMS (https://wams.online/our_team/ira-s-pastor/), and member of the World Economic Forum's Human Enhancement council (https://www.weforum.org/people/ira-pastor).

Monday Night - Amad Painter - and Theresa J Morris will cover and Ira will be here Monday Night!  Chief Executive Officer, Bioquark Inc. Ira S. Pastor - Chief Executive Officer – Bioquark Inc. (www.bioquark.com) - a novel life sciences company focused on inducible, endogenous regeneration and cellular repair, to bring an end to many of the most devastating ailments associated with human disease, degeneration, and death - 30 years of experience across multiple sectors of the pharmaceutical industry including pharmaceutical commercialization, biotech drug development, managed care, distribution, OTC, and retail; Served as VP, Business Development for drug development company Phytomedics Inc., raising $40 million of private equity, consummating over $50 million of licensing deals, and bringing lead drug candidate from discovery stage to Phase III development; Prior to that, employed by SmithKline Beecham Pharmaceuticals working in sales, marketing, and business strategy positions. Mr. Pastor has also served as Vice President of Corporate Development for the pharmacy benefit management company Prescription Delivery Systems (acquired by Cigna Health Insurance); MBA, Temple University; BS, Pharmacy, Rutgers University. He is also a Board Member of RegenerAge SAPI de CV, (www.regenerage.clinic/en/) a clinical company focused on expedited translational therapeutic applications of regenerative and rejuvenative healthcare interventions, the Reanima Project (http://www.reanima.tech), member of the Executive Council of the World Academy of Medical Science – WAMS (https://wams.online/our_team/ira-s-pastor/), and member of the World Economic Forum's Human Enhancement council (https://www.weforum.org/people/ira-pastor).

Ira Pastor,  is the Chief Executive Officer of Bioquark Inc. He has over 30 years of experience across multiple sectors of the pharmaceutical industry.  These sectors include pharmaceutical commercialization, biotech drug development, managed care, distribution, OTC, and retail.  Ira has served as VP, Business Development for drug development company Phytomedics Inc.  Ira spearheaded raising $40 million of private equity, consummating over $50 million of licensing deals, and bringing lead drug candidate from discovery stage to Phase III development.  Prior to that, Ira was employed by SmithKline Beecham Pharmaceuticals working in sales, marketing, and business strategy positions. Mr. Pastor has also served as Vice President of Corporate Development for the pharmacy benefit management company Prescription Delivery Systems (acquired by Cigna Health Insurance).  He earned his MBA from Temple University and his BS, Pharmacy from Rutgers University. In addition, Ira is also a Board Member of RegenerAge SAPI de CV, (www.regenerage.clinic/en/.) a clinical company focused on expedited translational therapeutic applications of regenerative and rejuvenative healthcare interventions.  He also serves on the Reanima Project (http://www.reanima.tech),and is a member of the World E.conomic Forum’s  Human Enhancement council (https://www.weforum.org/people/ira-pastor). Ira Pastor - Pharmacist to Entrepreneur Ira grew up in the Philadelphia area and was a pharmacist by training.  He then pursued a degree in business. Ira’s entrepreneur training dates back to his father, a naval shipman in WW2.  His father was also a pharmacist by trade and built a successful community pharmacy.  At an early age, Ira saw his father’s determination and work ethic during the depression.  Additionally, his dad’s military background was an important factor for instilling these characteristics. Passion of Regenerating, Repairing and Healing As Ira grew up in the family pharmacy business, he knew early on that he would be a pharmacist.  He worked side by side with his father and eventually evolved to the next phase-big biotech questions.  Ira was missing the entrepreneurial spirited angle and needed something more tangible so he jumped into a smaller biotech.  Bioquark and 3 R’s. Regeneration Repair Rejuvenation “How we can do a better job of regenerating, repairing and healing people; veterans fall in a major way in that category from some of the most traumatic, chronic and acute damage that are experienced.” – Ira Pastor Bioquark’s Mission “How we can move as an industry to addressing these much bigger problems associated with human degeneration, deterioration and death?”- Ira Pastor Don’t forget to leave us a 5-star rating and review if you enjoyed the show. We would love to hear from you! Check out these links for Ira Pastor Bioquark Webiste Join the Veteran on the Move on Facebook! Check out Veteran on the Move on Facebook to connect with our guests! It’s a great place where you can stay in touch with other veterans who are transitioning to entrepreneurship.  Get updates and free gouge on the people, programs and resources to help you in your transition to entrepreneurship. Veteran On the Move podcast has published over 200 episodes. Our listeners have the opportunity to hear in-depth interviews conducted by host Joe Crane . The podcast features people, programs and resources to assist veterans in their transition to entrepreneurship.  As a result, Veteran On the Move has over 1,000,000 verified downloads through Stitcher Radio, Sound Cloud, itunes and RSS Feed Syndication making it one of the most popular Military Entrepreneur Shows on the Internet Today.

Ira S. Pastor is the CEO of Bioquark, a life sciences company, developing proprietary combinatorial biologics for the regeneration and repair of human organs and tissues. Ira has over 30 years of pharmaceutical experience. He serves as a board member at multiple companies and organizations including RengerAge, the Reanima Project, The World Academy of Medical Science and the World Economic Forum’s Human Enhancement.This Episode We Discuss…Regeneration and repair of human organs and tissuesNatural regenerative capability of humansEffect of agePotential role of telomeraseBioquark’s area of focus in regenerationConditions that could potentially benefit from regeneration researchGenetics role in regenerationResearch on animals regenerative abilitiesGrowing organs outside the human body and its impact on the organ donor systemSomatic reversion and how it differs from other gene therapiesLearn more on Bioquark’s website and stay updated by following them on Facebook.Stay tuned for the next new episode of DNA Today on September 7th, 2018. New episodes are released on the first and third Fridays of the month. See what else I am up to on Twitter, Instagram, Facebook and iTunes. Questions/inquiries can be sent to info@DNApodcast.com.

We are going to take a little different turn this week and perhaps take a look into the future a little bit.   We glad to have with us, Ira Pastor, Chief Executive Officer – Bioquark Inc.    Ira has over 30 years of experience across multiple sectors of the pharmaceutical industry.  Currently, he is also a Board Member of RegenerAge  a clinical company focused on expedited translational therapeutic applications of regenerative and rejuvenative healthcare interventions, the Reanima Project (http://www.reanima.tech), and member of the World Economic Forum's Human Enhancement council.    Ira's company is applying a technology called combinatory biologics to essentially regrow tissue! check this show out....   Learn more about Ira and his work at BioQuark here

Join host Amy Zellmer as she speaks with Ira Pastor. Ira Pastor - Chief Executive Officer – Bioquark Inc. (www.bioquark.com) - Over 30 years of experience across multiple sectors of the pharmaceutical industry including pharmaceutical commercialization, biotech drug development, managed care, distribution, OTC, and retail; Served as VP, Business Development for drug development company Phytomedics Inc., raising $40 million of private equity, consummating over $50 million of licensing deals, and bringing lead drug candidate from discovery stage to Phase III development; Prior to that, employed by SmithKline Beecham Pharmaceuticals working in sales, marketing, and business strategy positions. Mr. Pastor has also served as Vice President of Corporate Development for the pharmacy benefit management company Prescription Delivery Systems (acquired by Cigna Health Insurance); MBA, Temple University; BS, Pharmacy, Rutgers University; He is also a Board Member of RegenerAge SAPI de CV, (www.regenerage.clinic/en/) a clinical company focused on expedited translational therapeutic applications of regenerative and rejuvenative healthcare interventions, the Reanima Project (http://www.reanima.tech), member of the Executive Council of the World Academy of Medical Science – WAMS (https://wams.online/our_team/ira-s-pastor/), and member of the World Economic Forum's Human Enhancement council (https://www.weforum.org/people/ira-pastor). sponsored by: Minnesota Functional Neurology, DC

Broken & Beautiful with Erin DooleyErin R. Dooley was born and raised in the suburbs of Chicago. She earned her BS in Business from University of Dayton. Erin began screenwriting at age 24 and made her directorial debut with the award-winning film "Broken & Beautiful." Erin founded D.A.S.H. Entertainment in 2010 to produce her feature and short films. www.brokenandbeautifulmovie.comStrategies for Living Longer with Ira PastorIra Pastor is Chief Executive Officer of Bioquark Inc, with over 30 years of experience across multiple sectors of the pharmaceutical industry. He is also a Board Member of RegenerAge SAPI de CV, a clinical company focused on expedited translational therapeutic applications of regenerative and rejuvenative healthcare interventions, the Reanima Project, member of the Executive Council of the World Academy of Medical Science – WAMS and member of the World Economic Forum’s Human Enhancement council.www.bioquark.com

Ira has over 30 years of experience across multiple sectors of the pharmaceutical industry including pharmaceutical commercialisation, biotech drug development, managed care, distribution, OTC, and retail; Served as VP, Business Development for drug development company Phytomedics Inc., raising $40 million of private equity, consummating over $50 million of licensing deals, and bringing lead drug candidate from discovery stage to Phase III development.Prior to that, employed by SmithKline Beecham Pharmaceuticals working in sales, marketing, and business strategy positions. Ira has also served as Vice President of Corporate Development for the pharmacy benefit management company Prescription Delivery Systems (acquired by Cigna Health Insurance); He has an MBA, Temple University and a BS, Pharmacy, Rutgers University. He is also a Board Member of RegenerAge SAPI de CV, (www.regenerage.clinic/en/) a clinical company focused on expedited translational therapeutic applications of regenerative and rejuvenative healthcare interventions, the Reanima Project (http://www.reanima.tech), member of the Executive Council of the World Academy of Medical Science – WAMS (https://wams.online/our_team/ira-s-pastor/), and member of the World Economic Forum's Human Enhancement council (https://www.weforum.org/people/ira-pastor).He runs Bioquark, which is focused on the development and commercialisation of a novel range of biologic based products and services that have the ability to alter the biological regulatory state of human tissues and organs, with the goal of curing a wide range of diseases.Web: http://bioquark.com LinkedIn: https://www.linkedin.com/in/iraspastorTwitter: https://twitter.com/irat1onal Facebook company page: https://www.facebook.com/Bioquark Facebook profile: https://www.facebook.com/ira.pastor.7

Ira Pastor - Chief Executive Officer – Bioquark Inc. - 30 years of experience across multiple sectors of the pharmaceutical industry including pharmaceutical commercialization, biotech drug development, managed care, distribution, OTC, and retail; Served as VP, Business Development for drug development company Phytomedics Inc., raising $40 million of private equity, consummating over $50 million of licensing deals, and bringing lead drug candidate from discovery stage to Phase III development; Prior to that, employed by SmithKline Beecham Pharmaceuticals working in sales, marketing, and business strategy positions. Mr. Pastor has also served as Vice President of Corporate Development for the pharmacy benefit management company Prescription Delivery Systems (acquired by Cigna Health Insurance); MBA, Temple University; BS, Pharmacy, Rutgers University More information about the ReAnima Project can be found here.